3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
65
Ovarian Neoplasms
8
Neoplasm Metastasis
8
Endometrial Neoplasms
6
Neoplasms
5
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Hereditary Sensory and Autonomic Neuropathies
4
Carcinoma, Non-Small-Cell Lung
4
Advanced Breast Cancer
4
Squamous Cell Carcinoma of Head and Neck
3
Neoplasms by Site
3
Colorectal Neoplasms
3
Breast Diseases
3
Small Cell Lung Carcinoma
2
Melanoma
2
Locally Advanced (Inoperable) or Metastatic Breast Cancer
2
Head and Neck Neoplasms
2
Uterine Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Unilateral Breast Neoplasms
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Salivary Gland Neoplasms
1
Recurrence
1
Multiple Endocrine Neoplasia Type 1
1
Malignant Neoplasms of Female Genital Organs
1
Lung Neoplasms
1
Interventions
Fluorouracil
14
Nivolumab
13
Oxaliplatin
12
Leucovorin
11
Paclitaxel
7
Capecitabine
7
pembrolizumab
6
Radiotherapy
5
Cisplatin
5
Taxes
4
Specimen Handling
4
Radiation
4
Irinotecan
4
Drug Therapy
4
dehydroftorafur
3
Trastuzumab
3
Ramucirumab
3
Magnetic Resonance Spectroscopy
3
Folfox protocol
3
zimberelimab
2
zanidatamab
2
trastuzumab deruxtecan
2
futibatinib
2
Levoleucovorin
2
Endoscopy, Digestive System
2
Endoscopy
2
Carboplatin
2
Biopsy
2
zolbetuximab
1
trastuzumab biosimilar HLX02
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Fulvestrant
×
90 days
×
Clear all
No trials found.